Alcidion Group Limited

Alcidion Group Limited

AASX:ALC
0.10
AUD
+0.00
(-1.03%)
0.00EPS
61.71P/E
141.07MMarket Cap
Feb 25Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
Revenue per Share
- -
- -
0.01
0.01
- -
0.02
0.02
0.03
0.03
0.03
0.03
- -
0.03
Basic EPS, GAAP
- -
- -
-0.01
-0.01
- -
- -
- -
- -
- -
- -
-0.01
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.03
0.03
0.01
0.01
0.01
0.02
0.03
0.04
0.07
0.07
0.06
- -
0.07
Tangible Book Value per Share
0.03
0.03
0.01
0.01
- -
-0.02
0.01
0.02
- -
-0.01
-0.01
- -
- -
Basic Weighted Avg Shares
141
141
412
333
620
821
953
1,020
1,164
1,268
1,316
1,343
1,343
Sales/Revenue/Turnover
- -
- -
3
2
3
17
19
26
34
40
37
- -
42
Operating Margin (%)
- -
- -
-94.92
-135.3
-112.76
-0.94
-22.06
-1.73
-5.03
-11.7
-23.42
- -
-17.99
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
2
3
4
- -
5
Net Income, GAAP
- -
- -
-3
-2
-2
- -
-3
-2
-4
-4
-8
- -
2
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-89.53
-86.6
-69.57
-0.5
-16.58
-8.67
-12.84
-8.95
-22.71
- -
5.47
Working Capital
4
4
7
5
2
-10
11
17
2
- -
-1
- -
5
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
2
1
1
- -
- -
Total Equity
4
4
7
5
3
13
30
45
94
90
87
- -
91
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-3.62
-7.16
-49.3
-34.36
-47.72
-1.02
-14.32
-5.99
-6.34
-3.93
-9.51
- -
- -

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
37
2025
- -
- -
- -
2026
- -
- -
42

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.01
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Kate Quirke
Full Time Employees
141
Sector
Technology services
Industry
Packaged software
Address
9 Yarra Street South Yarra VIC Australia 3141
IPO Date
Jun 24, 2011
Business
Alcidion Group Limited, along with its associated entities, specialises in crafting and licensing intelligent healthcare software across Australia, New Zealand, and the United Kingdom. The company’s core offering is Miya Precision, a sophisticated Fast Healthcare Interoperability Resources (FHIR)-based platform designed to enhance clinical and operational workflows. This comprehensive suite incorporates various modules for managing electronic patient records, patient flow, virtual care, and providing real-time clinical decision support through integrated data and predictive analytics. Among its key solutions, Alcidion offers Smartpage, a mobile and web-based communication and task management system for both clinical and non-clinical hospital staff, ensuring secure, efficient messaging and task allocation. Its patient monitoring capabilities include Miya Observations and Assessments, formerly Patientrack, which facilitates real-time vital sign capture and early warning alerts to identify patient deterioration. Additionally, the company provides the Silverlink Patient Administration System (PAS), which integrates with Miya Precision to offer a modular Electronic Patient Record (EPR) solution. ExtraMed patient flow management software has also been integrated into its Miya offerings, enhancing real-time visibility of patient movement. Beyond software, Alcidion delivers extensive services covering product implementation, ongoing support and maintenance, systems integration, and advanced data analytics. In recent financial reporting, Alcidion achieved a revenue of $40.8 million in FY25, a 10% increase from the prior year, with Annual Recurring Revenue climbing 31% to $28.5 million. The company reported $17.7 million in cash reserves and no debt at the end of FY25. Recent strategic milestones include a significant 10-year, $39 million Electronic Patient Record contract with North Cumbria NHS Trust in the UK, and an expanded agreement with Leidos Australia. With its origins dating back to 2000 and headquartered in South Yarra, Australia, Alcidion continues its mission to transform healthcare by providing proactive, smart technology solutions globally.